Search Results - "Thomas P. Blackburn"
-
1
Golexanolone reduces glial activation in the striatum and improves non-motor and some motor alterations in a rat model of Parkinson's disease
Published in Frontiers in aging neuroscience (21-06-2024)“…Parkinson's disease (PD) affects more than 6 million people worldwide. Along with motor impairments, patients and animal models exhibiting PD symptoms also…”
Get full text
Journal Article -
2
Depressive disorders: Treatment failures and poor prognosis over the last 50 years
Published in Pharmacology research & perspectives (01-06-2019)“…Depression like many diseases is pleiotropic but unlike cancer and Alzheimer's disease for example, is still largely stigmatized and falls into the dark…”
Get full text
Journal Article -
3
Neurological drug development: A guide for a start-up biotech
Published in Neurobiology of disease (01-01-2014)Get full text
Journal Article -
4
Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist
Published in Nature medicine (01-08-2002)“…Melanin concentrating hormone (MCH) is an orexigenic hypothalamic neuropeptide, which plays an important role in the complex regulation of energy balance and…”
Get full text
Journal Article -
5
The promise of molecular science in brain health. What breakthroughs are anticipated in the next 20 years?
Published in Cerebral circulation - cognition and behavior (01-01-2024)“…•In the past twenty years molecular science has delivered progress in therapeutic antibodies, biochemical markers, gene therapy and drug re-purposing.•Areas of…”
Get full text
Journal Article -
6
Anxiolytic- and Antidepressant-like Profiles of the Galanin-3 Receptor ($Gal_3$) Antagonists SNAP 37889 and SNAP 398299
Published in Proceedings of the National Academy of Sciences - PNAS (29-11-2005)“…The neuropeptide galanin mediates its effects through the receptor subtypes$Gal_1$,$Gal_2$, and$Gal_3$and has been implicated in anxiety-and depression-related…”
Get full text
Journal Article -
7
The GABA system, a new target for medications against cognitive impairment—Associated with neuroactive steroids
Published in Journal of internal medicine (01-09-2023)“…The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging…”
Get full text
Journal Article -
8
Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment
Published in Neuroscience and biobehavioral reviews (01-06-2024)“…Neuroinflammation accompanies several brain disorders, either as a secondary consequence or as a primary cause and may contribute importantly to disease…”
Get full text
Journal Article -
9
Selecting Double Bond Positions with a Single Cation-Responsive Iridium Olefin Isomerization Catalyst
Published in Journal of the American Chemical Society (24-02-2021)“…The catalytic transposition of double bonds holds promise as an ideal route to alkenes of value as fragrances, commodity chemicals, and pharmaceuticals; yet,…”
Get full text
Journal Article -
10
Effects of a triangular nanocage structure on the binding of neutral and anionic ligands to CoII and ZnII porphyrins
Published in Journal of coordination chemistry (28-10-2022)“…Interactions of neutral pyridine ligands and anionic benzoate ligands with the metalloporphyrin walls of M 6 L 3 nanocages (M = [(tmeda)Pt] 2+ , L =…”
Get full text
Journal Article -
11
Golexanolone, a GABAA receptor modulating steroid antagonist, restores motor coordination and cognitive function in hyperammonemic rats by dual effects on peripheral inflammation and neuroinflammation
Published in CNS neuroscience & therapeutics (01-11-2022)“…Aims Hyperammonemic rats show peripheral inflammation, increased GABAergic neurotransmission and neuroinflammation in cerebellum and hippocampus which induce…”
Get full text
Journal Article -
12
Editorial overview: Preface to ‘a tribute to professor Norman Bowery’
Published in Current opinion in pharmacology (01-08-2017)Get full text
Journal Article -
13
In memory of Norman Bowery (1944–2016)
Published in Current opinion in pharmacology (01-08-2017)“…•An article in memory of Professor Norman Bowery.•Norman Bowery discovered the GABAB receptor.•He identified the mechanism of action of Baclofen as a GABAB…”
Get full text
Journal Article -
14
The medical benefit of 5-HT research
Published in Pharmacology, biochemistry and behavior (01-04-2002)“…5-HT research is now more than 50 years old, and it has generated a wealth of therapeutic agents, some of which have had a major impact on disease management…”
Get full text
Journal Article -
15
Trace amine receptors as targets for novel therapeutics: legend, myth and fact
Published in Current opinion in pharmacology (01-02-2003)“…Trace amines are attracting attention as neurotransmitters because they are believed to play a role in human disorders such as schizophrenia, depression,…”
Get full text
Journal Article -
16
Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study
Published in Synapse (New York, N.Y.) (01-02-2007)“…We examined the effect of the administration of the selective serotonin reuptake inhibitors (SSRIs) fluoxetine, citalopram, and paroxetine on the activity of…”
Get full text
Journal Article -
17
3-Arylimino-2-indolones Are Potent and Selective Galanin GAL3 Receptor Antagonists
Published in Journal of medicinal chemistry (29-06-2006)“…A series of 3-imino-2-indolones are the first published, high-affinity antagonists of the galanin GAL3 receptor. One example,…”
Get full text
Journal Article -
18
5-ht6 receptors as emerging targets for drug discovery
Published in Annual review of pharmacology and toxicology (01-01-2000)“…5-ht6 receptors are the latest serotonin receptors to be identified by molecular cloning. Their high affinity for a wide range of drugs used in psychiatry,…”
Get full text
Journal Article -
19
-
20
The acute and chronic administration of the 5-HT2B/2C receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study
Published in Synapse (New York, N.Y.) (15-06-2006)“…This study examined the effect of the acute and chronic administration of the 5‐HT2B/2C receptor antagonist N‐(1‐methyl‐5‐indolyl)‐N′‐(3‐pyridyl) urea…”
Get full text
Journal Article